The global anastomosis devices market accounted for US $ 2,219 Mn in 2020 and is expected to reach US $ 3,822 Mn by 2028 with a considerable CAGR of 7.1% during the forecast period of 2021 to 2028.
An anastomosis is a surgical joining of two structures. It usually refers to a connection formed between tubular structures such as blood vessels or intestine loops. It is a surgical procedure that connects two structures and is performed after an organ has been resected to connect the remaining sections. It is a vital step in surgical procedure with a high risk of complications that necessitates the use of highly advanced and efficient devices. Furthermore, with the introduction of off-pump coronary artery bypass transplanting and minimally invasive coronary artery bypass grafting, considerable efforts have been made to facilitate graft-to-coronary anastomosis construction. As a result, several anastomotic devices have been founded. While the desirable anastomotic device should be simple to use, a number of design constraints must be met to produce a symmetrically optimal anastomosis with negligible endothelial damage and a blood-exposed non-intimal surface.
Increase in the prevalence of cardiovascular diseases
Growing demand for minimally invasive surgeries
An anastomotic leak is one of the difficulties associated with anastomosis
Lack of awareness in the underdeveloped economies
Rapid technological advancement and a favorable reimbursement situation for cardiac procedures
|Anastomosis Devices Market
|Market Size 2020
|US$ 2,219 Mn
|Market Forecast 2028
|US$ 3,822 Mn
|7.1% During 2021 - 2028
|2017 - 2028
|2021 - 2028
|By Type, By Application, By End-User and By Geography
|North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|Key Companies Profiled
|Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew Inc, Medtronic plc, EndoEvolution LLC, Intuitive Surgical, Inc., CryoLife, Inc., Boston Scientific Corporation, Péters Surgical, Biosintex, Baxter International, Inc., and Meril Life Sciences.
|Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
10 hrs of free customization and expert consultation
Anastomosis Devices Market Dynamics
The growing number of people being hospitalized with cardiovascular and gastrointestinal disorders across multiple regions will drive anastomosis device acceptance. The devices, which are commonly used in coronary bypass surgeries, will help improve the left ventricular system's function and increase a patient's survival rate, which will increase market demand for anastomosis devices. Furthermore, the COVID-19 pandemic has increased demand for healthcare equipment such as masks, face shields, and other protective medical equipment. With an increase in the number of COVID-19 cases worldwide, the demand for medical supplies from both health care providers and the general public for precautionary measures are increasing. In addition, as the pandemic situation gradually improves, the market for anastomosis devices is expected to rise significantly, as the virus was also responsible for an increase in the number of cardiovascular cases worldwide. In addition, challenges associated with anastomoses, such as an anastomotic leak, rising device costs, and the extensive medical information required for the launch of new products, are limiting the growth of the anastomosis market.
Market By Type
Surgical Sealants and Adhesives
Surgical staplers are medical equipment that can be used to close surgical wounds or perforations instead of sutures. Surgical staplers are typically used for the larger surgical wounds, both internally and externally, that stitches may be unable to handle. The C-section is a common process that utilizes surgical staples, which may help to reduce damaged tissue and healing time. However, the rising adoption of surgical staplers, particularly in developed economies, as well as the availability of advanced technological product offerings as a result of major industry players' robust R&D programs, are fueling the market growth. Furthermore, the rising prevalence of cardiovascular diseases, as well as an increase in the global geriatric population, is driving the market growth.
Market By Application
According to the Keimyung University School of Medicine, the number of cardiovascular surgeries is expected to rise steadily from 10,581 in 2014 to 15,501 in 2040, representing a 46.5% increase. The demand for cardiovascular surgery is generally inter-related to population structure, and it is expected that the older population of age 65 and over will increase to nearly 10 million over the forecasting period due to the dramatic aging of the global population. However, anastomosis devices may have a wide range of applications in the treatment of cardiovascular conditions, as surgeons use minimally invasive techniques to perform surgical procedures. The use of anastomosis devices can assist healthcare professionals in performing high-precision surgeries, which will drive the use of anastomosis devices.
Market By End-User
In terms of end-user, hospitals accounted for the largest share of the anastomosis devices market in 2020. The growing health care facilities in the hospital, increasing patient preference for hospitalization, and the availability of qualified healthcare professionals and advanced technological facilities all contribute to this end-user segment's size.
Anastomosis Devices Market Regional Overview
Middle East & Africa
North America dominates the global anastomosis devices market in 2020, owing to favorable reimbursement conditions in the United States, rising cancer incidence in the region, and the implementation of the new funding model for Canadian hospitals. Furthermore, increasing access to health care assistance, increased awareness of CVD and CHD, increasing disposable income, and a well-established R&D infrastructure all contribute to growth. Additionally, an increase in the number of surgeries performed each year, as well as a shift from conventional suture-based surgical operations to modern surgical devices, are supporting factors for industry revenue.
Some of the key players in global anastomosis devices market are Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew Inc, Medtronic plc, EndoEvolution LLC, Intuitive Surgical, Inc., CryoLife, Inc., Boston Scientific Corporation, Péters Surgical, Biosintex, Baxter International, Inc., and Meril Life Sciences.
The estimated value of Global Anastomosis Devices Market in 2020 was accounted to be US$ 2,219 Mn and market projected to reach US$ 3,822 by 2028
The projected CAGR of Anastomosis Devices Market during the analysis period of 2021 to 2028 is 7.1%
The prominent players of the global anastomosis devices market involve Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew Inc, Medtronic plc, EndoEvolution LLC, Intuitive Surgical, Inc., CryoLife, Inc., Boston Scientific Corporation, Péters Surgical, Biosintex, Baxter International, Inc., and Meril Life Sciences.
North America held the dominating share for anastomosis devices during the analysis period of 2021 to 2028
Asia Pacific region exhibited fastest growing CAGR for anastomosis devices during the analysis period of 2021 to 2028
Increase in the prevalence of cardiovascular diseases as well as growing demand for minimally invasive surgeries are the prominent factors that fuel the growth of global anastomosis devices market
Based on type, surgical staplers segment held the maximum share for anastomosis devices market in 2020